Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Balmer

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pathology|September 5, 2006
Anti-pneumococcal antibody titre measurement: what useful information does it yield?Paul Balmer, Andrew J Cant, Ray Borrow
Vaccine|May 12, 2020
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studiesChris Webber, Paula Peyrani, Paul Balmer, et al.
Postgraduate Medicine|March 4, 2020
Understanding immunogenicity assessments for meningococcal serogroup B vaccinesPaul Balmer, Johannes Beeslaar, Jamie Findlow, et al.
Postgraduate Medicine|February 22, 2021
Potential public health impact of a <i>Neisseria meningitidis</i> A, B, C, W, and Y pentavalent vaccine in the United StatesLiping Huang, Sonya J Snedecor, Paul Balmer, et al.
Human Vaccines & Immunotherapeutics|March 23, 2018
Impact of meningococcal vaccination on carriage and disease transmission: A review of the literaturePaul Balmer, Cynthia Burman, Lidia Serra, et al.
Expert Review of Vaccines|June 18, 2015
PCVs in individuals at increased risk of pneumococcal disease: a literature reviewMark A Fletcher, Paul Balmer, Eric Bonnet, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135Gouri Lal, Paul Balmer, Helen Joseph, et al.
Vaccine|April 6, 2023
Modeling persistence of hSBA titers over time following a primary series and a booster dose of MenB-FHbpBing Cai, Paula Peyrani, Johannes Beeslaar, et al.
Epidemiology and Infection|December 5, 2024
Global epidemiology of serogroup Y invasive meningococcal disease: a literature reviewMyint Tin Tin Htar, Jamie Findlow, Paul Balmer, et al.
Vaccines|February 26, 2025
Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease ReboundJamie Findlow, Myint Tin Tin Htar, Rodolfo Villena, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pathology|September 5, 2006
Anti-pneumococcal antibody titre measurement: what useful information does it yield?Paul Balmer, Andrew J Cant, Ray Borrow
Vaccine|May 12, 2020
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studiesChris Webber, Paula Peyrani, Paul Balmer, et al.
Postgraduate Medicine|March 4, 2020
Understanding immunogenicity assessments for meningococcal serogroup B vaccinesPaul Balmer, Johannes Beeslaar, Jamie Findlow, et al.
Postgraduate Medicine|February 22, 2021
Potential public health impact of a <i>Neisseria meningitidis</i> A, B, C, W, and Y pentavalent vaccine in the United StatesLiping Huang, Sonya J Snedecor, Paul Balmer, et al.
Human Vaccines & Immunotherapeutics|March 23, 2018
Impact of meningococcal vaccination on carriage and disease transmission: A review of the literaturePaul Balmer, Cynthia Burman, Lidia Serra, et al.
Expert Review of Vaccines|June 18, 2015
PCVs in individuals at increased risk of pneumococcal disease: a literature reviewMark A Fletcher, Paul Balmer, Eric Bonnet, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135Gouri Lal, Paul Balmer, Helen Joseph, et al.
Vaccine|April 6, 2023
Modeling persistence of hSBA titers over time following a primary series and a booster dose of MenB-FHbpBing Cai, Paula Peyrani, Johannes Beeslaar, et al.
Epidemiology and Infection|December 5, 2024
Global epidemiology of serogroup Y invasive meningococcal disease: a literature reviewMyint Tin Tin Htar, Jamie Findlow, Paul Balmer, et al.
Vaccines|February 26, 2025
Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease ReboundJamie Findlow, Myint Tin Tin Htar, Rodolfo Villena, et al.
Pageof 8